✦ LIBER ✦

EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324

✍ Scribed by Komaki, Ritsuko; Paulus, Rebecca; Blumenschein, George R.; Curran, Walter J.; Robert, Francisco; Thariat, Juliette; Werner-Wasik, Maria; Choy, Hak; Hirsch, Fred R.; Ang, Kie Kian

Book ID: 126943244
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 815 KB
Volume: 112
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2014.06.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR expression as a predictor of surviv

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

✍ Robert Pirker; Jose R Pereira; Joachim von Pawel; Maciej Krzakowski; Rodryg Raml 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 872 KB

Survival Analysis of Patients With Stage

Survival Analysis of Patients With Stage I Non–Small-Cell Lung Cancer Using Clinical and DNA Repair Pathway Expression Variables

✍ Behera, Madhusmita; Heine, John J.; Sica, Gabriel L.; Fowler, Erin E.; Tran, Ha; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 477 KB

Prognostic Impact of Erythropoietin Expr

Prognostic Impact of Erythropoietin Expression and Erythropoietin Receptor Expression on Locoregional Control and Survival of Patients Irradiated for Stage II/III Non-Small-Cell Lung Cancer

✍ Dirk Rades; Cornelia Setter; Olav Dahl; Steven E. Schild; Frank Noack 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Expression of survivin and patients surv

Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies

✍ Li-nian Huang, Dong-sheng Wang, Yu-qing Chen, Cheng-ling Zhao… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 573 KB

Treatment Modality and Other Prognostic

Treatment Modality and Other Prognostic Factors for Overall Survival in Stage III Non-small Cell Lung Cancer (NSCLC): A Population-based Analysis

✍ Gomez, D.R.; Liao, K.; Chang, J.Y.; Liao, Z.; Shirvani, S.M.; Komaki, R.; Welsh, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A multicenter phase II study of cetuxima

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer

✍ Ramalingam, S.S.; Kotsakis, A.; Tarhini, A.A.; Heron, D.E.; Smith, R.; Friedland 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 740 KB